References
Han JH, Choi SJ, Kurihara N, Koide M, Oba Y, Roodman GD . Macrophage inflammatory protein-1 alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. Blood 2001; 97: 3349–3353.
Terpos E, Politou M, Szydlo R, Goldman JM, Apperley JF, Rahemtulla A . Serum levels of macrophage inflammatory protein-1 alpha (MIP-1alpha) correlate with the extent of bone disease and survival in patients with multiple myeloma. Br J Haematol 2003; 123: 106–109.
Haaber J, Abildgaard N, Knudsen LM, Dahl IM, Lodahl M, Thomassen M et al. Myeloma cell expression of 10 candidate genes for osteolytic bone disease. Only overexpression of DKK1 correlates with clinical bone involvement at diagnosis. Br J Haematol 2008; 140: 25–35.
Chen H, Campbell RA, Chang Y, Li M, Wang CS, Li J et al. Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis. Blood 2009; 113: 1992–2002.
Padró T, Ruiz S, Bieker R, Bürger H, Steins M, Kienast J et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 2000; 95: 2637–2644.
Uneda S, Hata H, Matsuno F, Harada N, Mitsuya Y, Kawano F et al. Macrophage inflammatory protein-1 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MM. Br J Haematol 2003; 120: 53–55.
Abe M, Hiura K, Ozaki S, Kido S, Matsumoto T . Vicious cycle between myeloma cell binding to bone marrow stromal cells via VLA-4-VCAM-1 adhesion and macrophage inflammatory protein-1alpha and MIP-1beta production. J Bone Miner Metab 2009; 27: 16–23.
Choi SJ, Oba Y, Gazitt Y, Alsina M, Cruz J, Anderson J et al. Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease. J Clin Invest 2001; 108: 1833–1841.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Roussou, M., Tasidou, A., Dimopoulos, M. et al. Increased expression of macrophage inflammatory protein-1α on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma. Leukemia 23, 2177–2181 (2009). https://doi.org/10.1038/leu.2009.130
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2009.130
- Springer Nature Limited
This article is cited by
-
Exploring the potential of combining IL-2-activated NK cells with an anti-PDL1 monoclonal antibody to target multiple myeloma-associated macrophages
Cancer Immunology, Immunotherapy (2023)
-
Evolving cancer–niche interactions and therapeutic targets during bone metastasis
Nature Reviews Cancer (2022)
-
Monoclonal antibody Daratumumab promotes macrophage-mediated anti-myeloma phagocytic activity via engaging FC gamma receptor and activation of macrophages
Molecular and Cellular Biochemistry (2022)
-
JunB is a key regulator of multiple myeloma bone marrow angiogenesis
Leukemia (2021)
-
Bone tissue quality in patients with monoclonal gammopathy of uncertain significance
Journal of Bone and Mineral Metabolism (2020)